{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:25:55Z","timestamp":1791876355604,"version":"4.3.4"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>To investigate the hemostatic efficacy of combined desmopressin (1-deamino-8-D-arginine vasopressin) and platelet transfusion in reducing hematoma expansion in acute, spontaneous intracerebral hemorrhage under antiplatelet treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design:<\/jats:title>\n            <jats:p>Single-center, nonrandomized study, performed between 2006 and 2014.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Setting:<\/jats:title>\n            <jats:p>Tertiary University Hospital of Tuebingen, Germany.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients:<\/jats:title>\n            <jats:p>Adult patients with intracerebral hemorrhage under antiplatelet treatment and follow-up CT at 24\u2009\u00b1\u200912 hours were included. Exclusion criteria included other intracerebral hemorrhage causes, anticoagulation, coagulopathy, or immediate surgery after baseline-CT.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Treatment with IV 1-deamino-8-D-arginine vasopressin (0.4 \u00b5g\/kg) + platelet transfusion (2 U) within 60 minutes of intracerebral hemorrhage under antiplatelet treatment diagnosis on brain imaging.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Measurements and Main Results:<\/jats:title>\n            <jats:p>Primary outcome was relative hematoma expansion from baseline to follow-up CT. Secondary outcomes included secondary intraventricular hemorrhage or hydrocephalus upon follow-up CT, thromboembolic events before discharge, and the 3-month functional outcome (assessed by modified Rankin Scale). One-hundred forty patients were included, 72 treated versus 68 controls. Times of symptom-onset-to-baseline-CT (hr) (median [interquartile range]: 3 [4] vs 5 [5]; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.468) and follow-up CT (26 [18] vs 19 [12]; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.352) were similar between groups. No between-group differences of total intracerebral hematoma expansion (%) (median [interquartile range]: 8.5 [12.4] vs 9.1 [16.5]; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.825), intraparenchymal (10.7 [23.1] vs 9.2 [20.7]; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.900), and intraventricular hematoma expansion (14.5 [63.2] vs 6.1 [40.4]; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.304) were noted. Among patients with hematoma expansion greater than or equal to 33% compared with baseline, 16 (52%) received treatment versus 15 (48%) controls. The occurrence of hematoma expansion greater than or equal to 33% was similar between groups (<jats:italic toggle=\"yes\">p<\/jats:italic> = 0.981). Rates of secondary intraventricular hemorrhage, hydrocephalus, and thromboembolic events were similar between groups. Treatment with 1-deamino-8-D-arginine vasopressin + platelet transfusion was not associated with the 3-month functional outcome (adjusted odds ratio, 1.570; 95% CI, 0.721\u20133.419; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.309).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>In line with the randomized Platelet Transfusion Versus Standard Care After Acute Stroke Due to Spontaneous Cerebral Hemorrhage Associated With Antiplatelet Therapy trial, our results suggest no hemostatic efficacy of early platelet transfusion in intracerebral hemorrhage under antiplatelet treatment. Contrary to results of preclinical and clinical nonintracerebral hemorrhage studies, adjunct 1-deamino-8-D-arginine vasopressin showed no benefit in limiting hematoma expansion or improving functional outcome.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ccm.0000000000004348","type":"journal-article","created":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T05:02:12Z","timestamp":1587013332000},"page":"1009-1017","source":"Crossref","is-referenced-by-count":39,"title":["Early Administration of Desmopressin and Platelet Transfusion for Reducing Hematoma Expansion in Patients With Acute Antiplatelet Therapy Associated Intracerebral Hemorrhage*"],"prefix":"10.1097","volume":"48","author":[{"given":"Annerose","family":"Mengel","sequence":"first","affiliation":[{"name":"Department of Neurology & Stroke, University Hospital T\u00fcbingen, T\u00fcbingen, Germany."},{"name":"Hertie-Institute for Clinical Brain Research, Eberhard-Karls University of T\u00fcbingen, T\u00fcbingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Ioanna","family":"Stefanou","sequence":"additional","affiliation":[{"name":"Department of Neurology & Stroke, University Hospital T\u00fcbingen, T\u00fcbingen, Germany."},{"name":"Hertie-Institute for Clinical Brain Research, Eberhard-Karls University of T\u00fcbingen, T\u00fcbingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina Anna","family":"Hadaschik","sequence":"additional","affiliation":[{"name":"Department of Neurology & Stroke, University Hospital T\u00fcbingen, T\u00fcbingen, Germany."},{"name":"Hertie-Institute for Clinical Brain Research, Eberhard-Karls University of T\u00fcbingen, T\u00fcbingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Wolf","sequence":"additional","affiliation":[{"name":"Department of Neurology & Stroke, University Hospital T\u00fcbingen, T\u00fcbingen, Germany."},{"name":"Hertie-Institute for Clinical Brain Research, Eberhard-Karls University of T\u00fcbingen, T\u00fcbingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Stadler","sequence":"additional","affiliation":[{"name":"Department of Neurology & Stroke, University Hospital T\u00fcbingen, T\u00fcbingen, Germany."},{"name":"Hertie-Institute for Clinical Brain Research, Eberhard-Karls University of T\u00fcbingen, T\u00fcbingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khouloud","family":"Poli","sequence":"additional","affiliation":[{"name":"Department of Neurology & Stroke, University Hospital T\u00fcbingen, T\u00fcbingen, Germany."},{"name":"Hertie-Institute for Clinical Brain Research, Eberhard-Karls University of T\u00fcbingen, T\u00fcbingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Lindig","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Neuroradiology, Eberhard-Karls University of T\u00fcbingen, T\u00fcbingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Ernemann","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Neuroradiology, Eberhard-Karls University of T\u00fcbingen, T\u00fcbingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Grimm","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Eberhard-Karls University of T\u00fcbingen, T\u00fcbingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Tatagiba","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Eberhard-Karls University of T\u00fcbingen, T\u00fcbingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Ziemann","sequence":"additional","affiliation":[{"name":"Department of Neurology & Stroke, University Hospital T\u00fcbingen, T\u00fcbingen, Germany."},{"name":"Hertie-Institute for Clinical Brain Research, Eberhard-Karls University of T\u00fcbingen, T\u00fcbingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Poli","sequence":"additional","affiliation":[{"name":"Department of Neurology & Stroke, University Hospital T\u00fcbingen, T\u00fcbingen, Germany."},{"name":"Hertie-Institute for Clinical Brain Research, Eberhard-Karls University of T\u00fcbingen, T\u00fcbingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,4,16]]},"reference":[{"key":"R1-20230816","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1161\/STROKEAHA.108.523209","article-title":"Incidence and 10-year survival of intracerebral hemorrhage in a population-based registry.","volume":"40","author":"Sacco","year":"2009","journal-title":"Stroke"},{"key":"R2-20230816","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1161\/STROKEAHA.108.524470","article-title":"Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII?","volume":"40","author":"Mayer","year":"2009","journal-title":"Stroke"},{"key":"R3-20230816","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1212\/01.wnl.0000208408.98482.99","article-title":"Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage.","volume":"66","author":"Davis","year":"2006","journal-title":"Neurology"},{"key":"R4-20230816","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S1474-4422(16)00110-1","article-title":"Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): A randomised trial.","volume":"15","author":"Steiner","year":"2016","journal-title":"Lancet Neurol"},{"key":"R5-20230816","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1056\/NEJMoa1707278","article-title":"Idarucizumab for dabigatran reversal - full cohort analysis.","volume":"377","author":"Pollack","year":"2017","journal-title":"N Engl J Med"},{"key":"R6-20230816","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1056\/NEJMoa1814051","article-title":"Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors.","volume":"380","author":"Connolly","year":"2019","journal-title":"N Engl J Med"},{"key":"R7-20230816","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMoa0707534","article-title":"Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage.","volume":"358","author":"Mayer","year":"2008","journal-title":"N Engl J Med"},{"key":"R8-20230816","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/S0140-6736(18)31033-X","article-title":"Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): An international randomised, placebo-controlled, phase 3 superiority trial.","volume":"391","author":"Sprigg","year":"2018","journal-title":"Lancet"},{"key":"R9-20230816","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1385\/NCC:1:1:47","article-title":"Treatment of acute intracerebral hemorrhage with epsilon-aminocaproic acid: A pilot study.","volume":"1","author":"Piriyawat","year":"2004","journal-title":"Neurocrit Care"},{"key":"R10-20230816","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/S0140-6736(16)30392-0","article-title":"Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): A randomised, open-label, phase 3 trial.","volume":"387","author":"Baharoglu","year":"2016","journal-title":"Lancet"},{"key":"R11-20230816","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/jth.13576","article-title":"Desmopressin for treatment of platelet dysfunction and reversal of antiplatelet agents: A systematic review and meta-analysis of randomized controlled trials.","volume":"15","author":"Desborough","year":"2017","journal-title":"J Thromb Haemost"},{"key":"R12-20230816","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/ALN.0b013e31818db18b","article-title":"Desmopressin reduces transfusion needs after surgery: A meta-analysis of randomized clinical trials.","volume":"109","author":"Crescenzi","year":"2008","journal-title":"Anesthesiology"},{"key":"R13-20230816","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1161\/STROKEAHA.114.006061","article-title":"Desmopressin improves platelet activity in acute intracerebral hemorrhage.","volume":"45","author":"Naidech","year":"2014","journal-title":"Stroke"},{"key":"R14-20230816","doi-asserted-by":"crossref","first-page":"298767","DOI":"10.1155\/2014\/298767","article-title":"Desmopressin acetate in intracranial haemorrhage.","volume":"2014","author":"Kapapa","year":"2014","journal-title":"Neurol Res Int"},{"key":"R15-20230816","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jocn.2019.05.032","article-title":"Cohort analysis of desmopressin effect on hematoma expansion in patients with spontaneous intracerebral hemorrhage and documented pre-ictus antiplatelet use.","volume":"66","author":"Schmidt","year":"2019","journal-title":"J Clin Neurosci"},{"key":"R16-20230816","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1097\/CCM.0000000000004021","article-title":"Retrospective assessment of desmopressin effectiveness and safety in patients with antiplatelet-associated intracranial hemorrhage.","volume":"47","author":"Feldman","year":"2019","journal-title":"Crit Care Med"},{"key":"R17-20230816","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2174\/157488607781668891","article-title":"Desmopressin 30 years in clinical use: A safety review.","volume":"2","author":"Vande Walle","year":"2007","journal-title":"Curr Drug Saf"},{"key":"R18-20230816","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12028-015-0222-x","article-title":"Guideline for reversal of antithrombotics in intracranial hemorrhage: A statement for healthcare professionals from the Neurocritical Care Society and Society of Critical Care Medicine.","volume":"24","author":"Frontera","year":"2016","journal-title":"Neurocrit Care"},{"key":"R19-20230816","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/01.STR.32.4.891","article-title":"The ICH score: A simple, reliable grading scale for intracerebral hemorrhage.","volume":"32","author":"Hemphill","year":"2001","journal-title":"Stroke"},{"key":"R20-20230816","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.neuroimage.2006.01.015","article-title":"User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability.","volume":"31","author":"Yushkevich","year":"2006","journal-title":"Neuroimage"},{"key":"R21-20230816","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1161\/STROKEAHA.111.613273","article-title":"Simplified modified rankin scale questionnaire: Reproducibility over the telephone and validation with quality of life.","volume":"42","author":"Bruno","year":"2011","journal-title":"Stroke"},{"key":"R22-20230816","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","article-title":"Interobserver agreement for the assessment of handicap in stroke patients.","volume":"19","author":"van Swieten","year":"1988","journal-title":"Stroke"},{"key":"R23-20230816","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa042991","article-title":"Recombinant activated factor VII for acute intracerebral hemorrhage.","volume":"352","author":"Mayer","year":"2005","journal-title":"N Engl J Med"},{"key":"R24-20230816","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2105\/AJPH.94.3.361","article-title":"Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: The TREND statement.","volume":"94","author":"Des Jarlais","year":"2004","journal-title":"Am J Public Health"},{"key":"R25-20230816","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1161\/01.STR.27.10.1783","article-title":"Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course.","volume":"27","author":"Kazui","year":"1996","journal-title":"Stroke"},{"key":"R26-20230816","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/STROKEAHA.112.670653","article-title":"The Modified Graeb Score: An enhanced tool for intraventricular hemorrhage measurement and prediction of functional outcome.","volume":"44","author":"Morgan","year":"2013","journal-title":"Stroke"},{"key":"R27-20230816","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s004670100571","article-title":"Perioperative management of central diabetes insipidus in kidney transplantation.","volume":"16","author":"Henne","year":"2001","journal-title":"Pediatr Nephrol"},{"key":"R28-20230816","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1515\/JPEM.1995.8.4.257","article-title":"Continuous infusion of vasopressin in comatose children with neurogenic diabetes insipidus.","volume":"8","author":"Lee","year":"1995","journal-title":"J Pediatr Endocrinol Metab"},{"key":"R29-20230816","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1212\/WNL.0b013e3182143317","article-title":"Defining hematoma expansion in intracerebral hemorrhage: Relationship with patient outcomes.","volume":"76","author":"Dowlatshahi","year":"2011","journal-title":"Neurology"},{"key":"R30-20230816","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(19)30195-3","article-title":"Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): A randomised, controlled, open-label, blinded endpoint phase 3 trial.","volume":"393","author":"Hanley","year":"2019","journal-title":"Lancet"},{"key":"R31-20230816","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMoa1603460","article-title":"Intensive blood-pressure lowering in patients with acute cerebral hemorrhage.","volume":"375","author":"Qureshi","year":"2016","journal-title":"N Engl J Med"},{"key":"R32-20230816","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s12028-012-9765-2","article-title":"CTA spot sign predicts hematoma expansion in patients with delayed presentation after intracerebral hemorrhage.","volume":"17","author":"Brouwers","year":"2012","journal-title":"Neurocrit Care"},{"key":"R33-20230816","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.06.014","article-title":"Variability in the use of platelet transfusion in patients with intracerebral hemorrhage: Observations from the ethnic\/racial variations of intracerebral hemorrhage study.","volume":"26","author":"Guerrero","year":"2017","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R34-20230816","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12028-018-00668-2","article-title":"Hematoma expansion differences in lobar and deep primary intracerebral hemorrhage.","volume":"31","author":"Roh","year":"2019","journal-title":"Neurocrit Care"},{"key":"R35-20230816","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s12028-019-00672-0","article-title":"Functional coagulation differences between lobar and deep intracerebral hemorrhage detected by rotational thromboelastometry: A pilot study.","volume":"31","author":"Roh","year":"2019","journal-title":"Neurocrit Care"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000004348","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:09:45Z","timestamp":1692144585000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000004348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,16]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000004348","relation":{},"ISSN":["0090-3493"],"issn-type":[{"value":"0090-3493","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4,16]]}}}